A 66-years-old female was diagnosed to have combined central retinal vein occlusion (CRVO) and branch retinal artery occlusion (BRAO). Colour fundus photograph \[[Fig. 1a](#F1){ref-type="fig"}\] showing multiple haemorrhages and pale ischaemic area superiorly (black arrow). In [Fig. 1b](#F1){ref-type="fig"}, fundus fluorescein angiography (FFA) shows delayed arterial filling and prolonged arteriovenous transit time. Multicolour imaging highlights the area of ischaemia (black arrow) and serous fluid in macular area as dark green as shown in [Fig. 1c](#F1){ref-type="fig"}. In Fig. [1d](#F1){ref-type="fig"} and [e](#F1){ref-type="fig"}, optical coherence tomography shows hyper-reflectivity of inner retinal layers (red arrow) and serous detachment (star), respectively.

![Colour fundus photograph (a) showing multiple haemorrhages, disc oedema, and pale ischaemic area superiorly (black arrow). Fundus fluorescein angiography (b) showing delayed arterial dye filling and prolonged arteriovenous transit time. Multicolour imaging (c) highlighting the area of ischaemia (black arrow) and showing greenish tinge in the area of macular oedema. Optical coherence tomography showing hyper-reflectivity of inner retinal layers (d) (red arrow) and increase in retinal thickness (e) in the corresponding areas](IJO-66-1862-g001){#F1}

Combined CRVO and BRAO is uncommon and the arterial occlusion is often missed.\[[@ref1][@ref2]\] Echocardiography, carotid Doppler ultrasound, and magnetic resonance imaging brain should be added whenever investigating a combined occlusion.\[[@ref3]\]
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